{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:20:03Z","timestamp":1789924803840,"version":"4.0.1"},"reference-count":77,"publisher":"Elsevier BV","issue":"8-9","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.neurol.2013.02.005","type":"journal-article","created":{"date-parts":[[2013,9,2]],"date-time":"2013-09-02T11:45:17Z","timestamp":1378122317000},"page":"640-649","source":"Crossref","is-referenced-by-count":40,"title":["The thymus in autoimmune Myasthenia Gravis: Paradigm for a tertiary lymphoid organ"],"prefix":"10.1016","volume":"169","author":[{"given":"J.-M.","family":"Weiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cufi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Le Panse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Berrih-Aknin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neurol.2013.02.005_bib0005","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/1531-8249(199910)46:4<559::AID-ANA3>3.0.CO;2-S","article-title":"Prevention of autoimmune attack by targeting specific T-cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis","volume":"46","author":"Aissaoui","year":"1999","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2013.02.005_bib0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nri1786","article-title":"Lymphoid neogenesis in chronic inflammatory diseases","volume":"6","author":"Aloisi","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.neurol.2013.02.005_bib0015","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/intimm\/dxh227","article-title":"IFN{alpha} enhances human B-cell chemotaxis by modulating ligand-induced chemokine receptor signaling and internalization","volume":"17","author":"Badr","year":"2005","journal-title":"Int Immunol"},{"issue":"6","key":"10.1016\/j.neurol.2013.02.005_bib0020","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.4049\/jimmunol.170.6.3392","article-title":"Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus","volume":"170","author":"Balabanian","year":"2003","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.neurol.2013.02.005_bib0025","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.neurol.2013.02.005_bib0030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0022-510X(91)90260-E","article-title":"Prognosis of myasthenia gravis: a multicenter follow-up study of 844\u00a0patients","volume":"106","author":"Beghi","year":"1991","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2013.02.005_bib0035","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.1987.tb51282.x","article-title":"The role of the thymus in myasthenia gravis: immunohistological and immunological studies in 115 cases","volume":"505","author":"Berrih-Aknin","year":"1987","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.neurol.2013.02.005_bib0040","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.21628","article-title":"CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia","volume":"66","author":"Berrih-Aknin","year":"2009","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2013.02.005_bib0045","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/WNL.34.1.66","article-title":"Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis","volume":"34","author":"Berrih","year":"1984","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2013.02.005_bib0050","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0003-4975(01)02678-9","article-title":"Predictors of outcome in thymectomy for myasthenia gravis","volume":"72","author":"Budde","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.neurol.2013.02.005_bib0055","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in Myasthenia Gravis","volume":"10","author":"Carr","year":"2011","journal-title":"BMC Neurol"},{"issue":"14","key":"10.1016\/j.neurol.2013.02.005_bib0060","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1212\/WNL.0b013e3181d7d884","article-title":"Detection of poliovirus-infected macrophages in thymus of patients with myasthenia gravis","volume":"74","author":"Cavalcante","year":"2010","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neurol.2013.02.005_bib0065","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ana.21902","article-title":"Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus","volume":"67","author":"Cavalcante","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2013.02.005_bib0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jneuroim.2008.06.028","article-title":"Thymus and Myasthenia Gravis: what can we learn from DNA microarrays?","volume":"201\u2013202","author":"Cizeron-Clairac","year":"2008","journal-title":"J Neuroimmunol"},{"issue":"10","key":"10.1016\/j.neurol.2013.02.005_bib0075","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.4049\/jimmunol.175.10.7021","article-title":"Constitutive activation of p38 and ERK1\/2 MAPKs in epithelial cells of myasthenic thymus leads to IL-6 and RANTES overexpression: effects on survival and migration of peripheral T and B cells","volume":"175","author":"Colombara","year":"2005","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.neurol.2013.02.005_bib0080","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1468-1331.2011.03636.x","article-title":"High anti-EBNA-1 IgG levels are associated with early-onset myasthenia gravis","volume":"19","author":"Csuka","year":"2012","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2013.02.005_bib0085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ana.23791","article-title":"Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis","volume":"73","author":"Cufi","year":"2013","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2013.02.005_bib0090","doi-asserted-by":"crossref","first-page":"R1208","DOI":"10.1186\/ar1806","article-title":"Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis","volume":"7","author":"De Klerck","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.neurol.2013.02.005_bib0095","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1096\/fasebj.22.2_supplement.473","article-title":"Anti-CXCL13 and anti-TNF{alpha} combination therapy in a mouse model of systemic lupus erythematosu","volume":"22","author":"Debra Bryce Gardner","year":"2008","journal-title":"FASEB J"},{"issue":"11","key":"10.1016\/j.neurol.2013.02.005_bib0100","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/ni723","article-title":"Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self","volume":"2","author":"Derbinski","year":"2001","journal-title":"Nat Immunol"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2013.02.005_bib0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2009.01.021","article-title":"Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling between IFN-gamma inducible protein 10 (IP-10) and its receptor CXCR3","volume":"209","author":"Feferman","year":"2009","journal-title":"J Neuroimmunol"},{"issue":"9","key":"10.1016\/j.neurol.2013.02.005_bib0110","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.4049\/jimmunol.174.9.5324","article-title":"Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis","volume":"174","author":"Feferman","year":"2005","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.neurol.2013.02.005_bib0115","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1053\/hupa.2001.27106","article-title":"B cells in epithelial and perivascular compartments of human adult thymus","volume":"32","author":"Flores","year":"2001","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.neurol.2013.02.005_bib0120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0165-5728(83)90031-0","article-title":"Subsets of lymphoid cells in blood and thymus in myasthenia gravis. Monoclonal antibody analysis","volume":"4","author":"Fujii","year":"1983","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.neurol.2013.02.005_bib0125","doi-asserted-by":"crossref","first-page":"887","DOI":"10.4049\/jimmunol.136.3.887","article-title":"Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis","volume":"136","author":"Fujii","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.neurol.2013.02.005_bib0130","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1405.027","article-title":"Genetic factors in autoimmune myasthenia gravis","volume":"1132","author":"Giraud","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.neurol.2013.02.005_bib0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1212\/WNL.55.1.7","article-title":"Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"55","author":"Gronseth","year":"2000","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurol.2013.02.005_bib0140","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-2249.1991.tb05625.x","article-title":"Individual germinal centres of myasthenia gravis human thymuses contain polyclonal activated B cells that express all the Vh and Vk families","volume":"83","author":"Guigou","year":"1991","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.neurol.2013.02.005_bib0145","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2013.02.005_bib0150","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jneuroim.2008.06.027","article-title":"The myasthenia gravis thymus: a rare source of human autoantibody-secreting plasma cells for testing potential therapeutics","volume":"201\u2013202","author":"Hill","year":"2008","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.neurol.2013.02.005_bib0155","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1189\/jlb.69.3.331","article-title":"Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines","volume":"69","author":"Hjelmstrom","year":"2001","journal-title":"J Leukoc Biol"},{"issue":"10","key":"10.1016\/j.neurol.2013.02.005_bib0160","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/eji.201242408","article-title":"MCP-1\/CCR2 interactions direct migration of peripheral B and T lymphocytes to the thymus during acute infectious\/inflammatory processes","volume":"42","author":"Hodge","year":"2012","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.neurol.2013.02.005_bib0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrd2734","article-title":"Chemokine receptor antagonists: overcoming developmental hurdles","volume":"8","author":"Horuk","year":"2009","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.1016\/j.neurol.2013.02.005_bib0170","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.it.2005.03.001","article-title":"Multi-faceted strategies to combat disease by interference with the chemokine system","volume":"26","author":"Johnson","year":"2005","journal-title":"Trends Immunol"},{"issue":"3","key":"10.1016\/j.neurol.2013.02.005_bib0175","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ana.22488","article-title":"Intrathymic Epstein-Barr virus infection is not a prominent feature of myasthenia gravis","volume":"70","author":"Kakalacheva","year":"2011","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2013.02.005_bib0180","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1750-3639.2008.00154.x","article-title":"Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis","volume":"18","author":"Kohler","year":"2008","journal-title":"Brain Pathol"},{"issue":"6","key":"10.1016\/j.neurol.2013.02.005_bib0185","article-title":"Myasthenia gravis following viral infection","volume":"20","author":"Korn","year":"1981","journal-title":"Eur Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2013.02.005_bib0190","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1568-9972(02)00085-X","article-title":"Chemokines in autoimmunity: from pathology to therapeutics","volume":"1","author":"Kunkel","year":"2002","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.neurol.2013.02.005_bib0195","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.dci.2003.09.006","article-title":"Chemokines","volume":"28","author":"Laing","year":"2004","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.neurol.2013.02.005_bib0200","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.cdd.4401611","article-title":"Human myoid cells protect thymocytes from apoptosis","volume":"12","author":"Le Panse","year":"2005","journal-title":"Cell death and differentiation"},{"key":"10.1016\/j.neurol.2013.02.005_bib0205","doi-asserted-by":"crossref","first-page":"7868","DOI":"10.4049\/jimmunol.177.11.7868","article-title":"Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative Myasthenia Gravis patients and the role of CCL21 in thymic hyperplasia","volume":"177","author":"Le Panse","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.neurol.2013.02.005_bib0210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1196\/annals.1405.019","article-title":"Regulatory and pathogenic mechanisms in human autoimmune myasthenia gravis","volume":"1132","author":"Le Panse","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.neurol.2013.02.005_bib0215","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2353\/ajpath.2007.070240","article-title":"Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status","volume":"171","author":"Leite","year":"2007","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.neurol.2013.02.005_bib0220","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.4049\/jimmunol.145.7.2115","article-title":"Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis","volume":"145","author":"Leprince","year":"1990","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.neurol.2013.02.005_bib0225","first-page":"310","article-title":"[Ultrastructural study of the thymus in patients with myasthenia gravis]","volume":"32","author":"Li","year":"1993","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"1","key":"10.1016\/j.neurol.2013.02.005_bib0230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0167-5699(92)90199-H","article-title":"Germinal centres in T-cell-dependent antibody responses","volume":"13","author":"Liu","year":"1992","journal-title":"Immunol Today"},{"issue":"5","key":"10.1016\/j.neurol.2013.02.005_bib0235","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1074-7613(00)80199-5","article-title":"BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis","volume":"12","author":"Luther","year":"2000","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.neurol.2013.02.005_bib0240","doi-asserted-by":"crossref","first-page":"424","DOI":"10.4049\/jimmunol.169.1.424","article-title":"Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis","volume":"169","author":"Luther","year":"2002","journal-title":"J Immunol"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2013.02.005_bib0245","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0022-510X(03)00087-X","article-title":"Video-assisted thoracoscopic extended thymectomy and extended transsternal thymectomy (T-3b) in non-thymomatous myasthenia gravis patients: remission after 6 years of follow-up","volume":"212","author":"Mantegazza","year":"2003","journal-title":"J Neurol Sci"},{"issue":"8","key":"10.1016\/j.neurol.2013.02.005_bib0250","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.4049\/jimmunol.173.8.4791","article-title":"A novel model for lymphocytic infiltration of the thyroid gland generated by transgenic expression of the CC chemokine CCL21","volume":"173","author":"Martin","year":"2004","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.neurol.2013.02.005_bib0255","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1172\/JCI113401","article-title":"Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients","volume":"81","author":"Melms","year":"1988","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.neurol.2013.02.005_bib0260","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1182\/blood-2005-06-2383","article-title":"The chemokine CXCL13 is a key molecule in autoimmune Myasthenia Gravis","volume":"108","author":"Meraouna","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.neurol.2013.02.005_bib0265","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ana.22522","article-title":"Lack of evidence for Epstein-Barr virus infection in myasthenia gravis thymus","volume":"70","author":"Meyer","year":"2011","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.neurol.2013.02.005_bib0270","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1182\/blood.V89.9.3287","article-title":"Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody","volume":"89","author":"Moulian","year":"1997","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.neurol.2013.02.005_bib0275","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/mus.10362","article-title":"Dendritic cells in hyperplastic thymuses from patients with myasthenia gravis","volume":"27","author":"Nagane","year":"2003","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.neurol.2013.02.005_bib0280","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00127893-200201000-00002","article-title":"Myasthenia gravis","volume":"8","author":"Nicolle","year":"2002","journal-title":"Neurologist"},{"issue":"6","key":"10.1016\/j.neurol.2013.02.005_bib0285","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/S0003-4975(99)00310-0","article-title":"Prognostic factors for myasthenia gravis treated by thymectomy: review of 61\u00a0cases","volume":"67","author":"Nieto","year":"1999","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.neurol.2013.02.005_bib0290","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/S0022-5223(03)00938-3","article-title":"The immunologic role of thymectomy in the treatment of myasthenia gravis: implication of thymus-associated B-lymphocyte subset in reduction of the anti-acetylcholine receptor antibody titer","volume":"126","author":"Okumura","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.neurol.2013.02.005_bib0295","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF02890168","article-title":"Immunohistochemical and enzyme histochemical contributions to the problem concerning the role of the thymus in the pathogenesis of myasthenia gravis","volume":"44","author":"Palestro","year":"1983","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"issue":"3","key":"10.1016\/j.neurol.2013.02.005_bib0300","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"Pevzner","year":"2012","journal-title":"J Neurol"},{"issue":"10","key":"10.1016\/j.neurol.2013.02.005_bib0305","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.4049\/jimmunol.174.10.5941","article-title":"Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis","volume":"174","author":"Po\u00eba-Guyon","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.neurol.2013.02.005_bib0310","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF02786481","article-title":"Lymphoid neo-organogenesis: lymphotoxin's role in inflammation and development","volume":"2\u20133","author":"Ruddle","year":"1999","journal-title":"Immunol Res"},{"issue":"6","key":"10.1016\/j.neurol.2013.02.005_bib0315","first-page":"e177","article-title":"Post-varicella myasthenia gravis","volume":"48","author":"Saha","year":"2007","journal-title":"Singapore Med J"},{"issue":"6","key":"10.1016\/j.neurol.2013.02.005_bib0320","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1371\/journal.ppat.0020062","article-title":"The thymus is a common target organ in infectious diseases","volume":"2","author":"Savino","year":"2006","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.neurol.2013.02.005_bib0325","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1172\/JCI115843","article-title":"Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravis","volume":"90","author":"Schonbeck","year":"1992","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.neurol.2013.02.005_bib0330","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.4049\/jimmunol.167.4.1935","article-title":"Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis","volume":"167","author":"Sims","year":"2001","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.neurol.2013.02.005_bib0335","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ana.410280303","article-title":"Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells","volume":"28","author":"Sommer","year":"1990","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2013.02.005_bib0340","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1084\/jem.191.6.1051","article-title":"An essential role for thymic mesenchyme in early T cell development","volume":"191","author":"Suniara","year":"2000","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.neurol.2013.02.005_bib0345","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/(SICI)1097-4598(200004)23:4<507::AID-MUS8>3.0.CO;2-#","article-title":"Marked increase in CD44-highly positive cells in hyperplastic thymuses from patients with Myasthenia gravis","volume":"23","author":"Utsugisawa","year":"2000","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.neurol.2013.02.005_bib0350","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/mus.20794","article-title":"Antigen-specific T-cell activation in hyperplastic thymus in myasthenia gravis","volume":"36","author":"Utsugisawa","year":"2007","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.neurol.2013.02.005_bib0355","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nri1222","article-title":"Homing and cellular traffic in lymph nodes","volume":"3","author":"von Andrian","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.neurol.2013.02.005_bib0360","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.4049\/jimmunol.157.8.3752","article-title":"Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis","volume":"157","author":"Wakkach","year":"1996","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.neurol.2013.02.005_bib0365","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.4049\/jimmunol.0801920","article-title":"CXCR4\/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus","volume":"182","author":"Wang","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.neurol.2013.02.005_bib0370","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.imbio.2012.05.006","article-title":"SDF-1\/CXCL12 recruits B cells and antigen-presenting cells to the thymus of autoimmune myasthenia gravis patients","volume":"218","author":"Weiss","year":"2013","journal-title":"Immunobiology"},{"issue":"47","key":"10.1016\/j.neurol.2013.02.005_bib0375","first-page":"3349","article-title":"[Correlation between pathogenesis of myasthenia gravis and thymus mature dendritic cells]","volume":"88","author":"Xia","year":"2008","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"4","key":"10.1016\/j.neurol.2013.02.005_bib0380","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3233\/HAB-1995-6405","article-title":"Macrophage subpopulations in the thymic hyperplasia of patients with myasthenia gravis","volume":"6","author":"Zhang","year":"1995","journal-title":"Hum Antibodies Hybridomas"},{"issue":"2","key":"10.1016\/j.neurol.2013.02.005_bib0385","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/clim.1999.4689","article-title":"Acetylcholine receptor alpha subunit mRNA expression in human thymus: augmented expression in myasthenia gravis and upregulation by interferon-gamma","volume":"91","author":"Zheng","year":"1999","journal-title":"Clin Immunol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378713008436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378713008436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T14:55:49Z","timestamp":1715957749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378713008436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":77,"journal-issue":{"issue":"8-9","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0035378713008436"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2013.02.005","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}